$XBI $68.60 | +5.68%
Table of Contents:
Covid Updates
$NVAX +8.2% Novavax Files for Emergency Use Authorization of COVID-19 Vaccine in Taiwan source
Pipeline Updates
$CKPT +17.4% Checkpoint Therapeutics Receives Pediatric Investigational Plan Waivers for Cosibelimab from the European Medicines Agency and U.K. Medicines & Healthcare Products Regulatory Agency source
$LNTH +7.4% Lantheus Announces First Patient Dosed in Phase 2 Clinical Trial of NM-01 to Monitor PD-L1 Expression in Non-Small Cell Lung Cancer (NSCLC) Patients source
Want to get weekly catalyst updates?
*We never spam you - unsubscribe anytime*
Business Updates
$
Posted by JM
Comentarios